Mitsuru Okada

1.3k total citations
44 papers, 955 citations indexed

About

Mitsuru Okada is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Mitsuru Okada has authored 44 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Nephrology. Recurrent topics in Mitsuru Okada's work include Renal Diseases and Glomerulopathies (9 papers), Liver Disease and Transplantation (7 papers) and Electrolyte and hormonal disorders (6 papers). Mitsuru Okada is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Liver Disease and Transplantation (7 papers) and Electrolyte and hormonal disorders (6 papers). Mitsuru Okada collaborates with scholars based in Japan, United States and Spain. Mitsuru Okada's co-authors include Isao Sakaida, Satoshi Hino, Kiwamu Okita, Kazuo Yoshioka, Tsukasa Takemura, Seiichiro Yamamoto, Seiji Kawazoe, Hiroshi Sakaue, Hidehiko Yanagida and Akira Kaneko and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Mitsuru Okada

40 papers receiving 932 citations

Peers

Mitsuru Okada
Baudouin Leclercq United States
Catherine Hall United States
Samir V. Parikh United States
Sha Fu China
M. Pétri United States
Baudouin Leclercq United States
Mitsuru Okada
Citations per year, relative to Mitsuru Okada Mitsuru Okada (= 1×) peers Baudouin Leclercq

Countries citing papers authored by Mitsuru Okada

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Okada more than expected).

Fields of papers citing papers by Mitsuru Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Okada. The network helps show where Mitsuru Okada may publish in the future.

Co-authorship network of co-authors of Mitsuru Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Okada. A scholar is included among the top collaborators of Mitsuru Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Okada. Mitsuru Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugimoto, Keisuke, et al.. (2021). Kimura’s disease with recurrent bilateral lacrimal gland involvement in a male Japanese child successfully treated with cyclosporine A. Allergy Asthma and Clinical Immunology. 17(1). 48–48. 4 indexed citations
3.
Okamoto, Nobuhiko, Yoshinori Iba, Tomoki Miyazawa, et al.. (2018). Three patients with Schaaf–Yang syndrome exhibiting arthrogryposis and endocrinological abnormalities. American Journal of Medical Genetics Part A. 176(3). 707–711. 18 indexed citations
4.
Ônishi, Yoshihiro, Takafumi Wakita, Shinichi Fukuhara, et al.. (2014). Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7. Clinical and Translational Gastroenterology. 5(2). e48–e48. 16 indexed citations
5.
Sakaida, Isao, Satoyoshi Yamashita, Tomoo Kobayashi, et al.. (2013). Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema. Journal of International Medical Research. 41(3). 835–847. 44 indexed citations
6.
Yanagida, Hidehiko, et al.. (2011). Focal segmental glomerulosclerosis and partial deletion of chromosome 6p: a case report. Clinical Nephrology. 76(7). 64–67. 4 indexed citations
7.
Miyazawa, Tomoki, Keisuke Sugimoto, Shinsuke Fujita, et al.. (2010). A Patient With Henoch-Schönlein Purpura Manifesting Unusual Symptoms and Clinical Course. JCR Journal of Clinical Rheumatology. 16(7). 338–340. 3 indexed citations
8.
Yasue, Shintaro, Hiroaki Masuzaki, Sadanori Okada, et al.. (2010). Adipose Tissue–Specific Regulation of Angiotensinogen in Obese Humans and Mice: Impact of Nutritional Status and Adipocyte Hypertrophy. American Journal of Hypertension. 23(4). 425–431. 92 indexed citations
9.
Okita, Kiwamu, Isao Sakaida, Mitsuru Okada, et al.. (2010). A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis. Journal of Gastroenterology. 45(9). 979–987. 44 indexed citations
10.
Tabata, Nobutada, Keisuke Sugimoto, Satoshi Ueda, et al.. (2009). Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis. Pediatrics International. 51(5). 759–760.
11.
Okada, Mitsuru, et al.. (2008). Association of INVS (NPHP2) mutation in an adolescent exhibiting nephronophthisis (NPH) and complete situs inversus. Clinical Nephrology. 69(2). 135–141. 12 indexed citations
12.
Fujimoto, Yoko, et al.. (2002). Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor. Clinical Nephrology. 58(8). 95–102. 13 indexed citations
13.
Yamamoto, Seiichiro, et al.. (2000). Clinical and radiological features in four adolescents with nutcracker syndrome. Pediatric Nephrology. 14(10-11). 1002–1005. 62 indexed citations
14.
Takemura, Tsukasa, Satoshi Hino, Yuka Murata, et al.. (1999). Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney International. 55(1). 71–81. 25 indexed citations
15.
Okada, Mitsuru, et al.. (1999). Cyclosporine Therapy in Children with Steroid-resistant Nephrotic Syndrome. Clinical and Experimental Nephrology. 3. 5 indexed citations
16.
Takemura, Tsukasa, Mitsuru Okada, Satoshi Hino, et al.. (1999). Course and outcome of tubulointerstitial nephritis and uveitis syndrome. American Journal of Kidney Diseases. 34(6). 1016–1021. 84 indexed citations
17.
Takemura, Tsukasa, Yuka Murata, Satoshi Hino, et al.. (1999). Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis. The Journal of Pathology. 189(3). 431–438. 26 indexed citations
18.
Terao, Takeshi, et al.. (1995). Lithium addition to neuroleptic treatment in chronic schizophrenia: a randomized, double‐blind, placebo‐controlled, cross‐over study. Acta Psychiatrica Scandinavica. 92(3). 220–224. 18 indexed citations
19.
Okada, Mitsuru, et al.. (1993). Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 422(5). 367–373. 29 indexed citations
20.
Yoshioka, Kazuo, Tsukasa Takemura, Norihisa Akano, et al.. (1992). IgA nephropathy in patients with congenital C9 deficiency. Kidney International. 42(5). 1253–1258. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026